APOBEC3G directly binds Hepatitis B virus core protein in cell and cell free systems

Virus Research

Volumn 151, Issue 2, 2010, Pages 213-219

  Zhao, Dongjiu ^a,b   Wang, Xianfeng ^b   Lou, Guohua ^b   Peng, Guoping ^b   Li, Jie ^b   Zhu, Haihong ^b   Chen, Feng ^b   Li, Shuping ^b   Liu, Dongcheng ^b   Chen, Zhi ^b   Yang, Zhenggang ^b  

^a ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b ZHEJIANG UNIVERSITY   (China)

Author keywords

APOBEC3G; Fluorescence resonance energy transfer; HBV core protein; RNA; Surface plasmon resonance

Indexed keywords

APOLIPOPROTEIN B MESSENGER RNA EDITING ENZYME CATALYTIC POLYPEPTIDE 3G; HEPATITIS B VIRUS CORE PROTEIN; UNCLASSIFIED DRUG; VIRUS PROTEIN; VIRUS RNA; APOBEC3G PROTEIN, HUMAN; CYTIDINE DEAMINASE; HEPATITIS B CORE ANTIGEN; PROTEIN BINDING;

ARTICLE; CELL FREE SYSTEM; CELL INTERACTION; CELL STRAIN HEPG2; FLUORESCENCE RESONANCE ENERGY TRANSFER; HEPATITIS B VIRUS; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; SURFACE PLASMON RESONANCE; CELL LINE; IMMUNOLOGY; LIVER CELL; METABOLISM; VIROLOGY; VIRUS REPLICATION;

CELL LINE; CELL-FREE SYSTEM; CYTIDINE DEAMINASE; FLUORESCENCE RESONANCE ENERGY TRANSFER; HEPATITIS B CORE ANTIGENS; HEPATITIS B VIRUS; HEPATOCYTES; HUMANS; PROTEIN BINDING; SURFACE PLASMON RESONANCE; VIRUS REPLICATION;

HEPATITIS B VIRUS;

EID: 77954214955     PISSN: 01681702     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.virusres.2010.05.009     Document Type: Article

References (35)

1. Aguiar R.S., Peterlin B.M. APOBEC3 proteins and reverse transcription. Virus Res. 2008, 134(1-2):74-85.
2. Alce T.M., Popik W. APOBEC3G is incorporated into virus-like particles by a direct interaction with HIV-1 Gag nucleocapsid protein. J. Biol. Chem. 2004, 279(33):34083-34086.
3. Bach D., Peddi S., Mangeat B., Lakkaraju A., Strub K., Trono D. Characterization of APOBEC3G binding to 7SL RNA. Retrovirology 2008, 5:54.
4. Baumert T.F., Rosler C., Malim M.H., von Weizsacker F. Hepatitis B virus DNA is subject to extensive editing by the human deaminase APOBEC3C. Hepatology 2007, 46(3):682-689.
5. Bourne C.R., Katen S.P., Fulz M.R., Packianathan C., Zlotnick A. A mutant Hepatitis B virus core protein mimics inhibitors of icosahedral capsid self-assembly (dagger). Biochemistry 2009, 48:1736-1742.
6. Burnett A., Spearman P. APOBEC3G multimers are recruited to the plasma membrane for packaging into human immunodeficiency virus type 1 virus-like particles in an RNA-dependent process requiring the NC basic linker. J. Virol. 2007, 81(10):5000-5013.
7. Cen S., Guo F., Niu M., Saadatmand J., Deflassieux J., Kleiman L. The interaction between HIV-1 Gag and APOBEC3G. J. Biol. Chem. 2004, 279(32):33177-33184.
8. Chiu Y.L., Greene W.C. The APOBEC3 cytidine deaminases: an innate defensive network opposing exogenous retroviruses and endogenous retroelements. Annu. Rev. Immunol. 2008, 26:317-353.
9. Douaisi M., Dussart S., Courcoul M., Bessou G., Vigne R., Decroly E. HIV-1 and MLV Gag proteins are sufficient to recruit APOBEC3G into virus-like particles. Biochem. Biophys. Res. Commun. 2004, 321(3):566-573.
10. Gao Y., Liu S.S., Qiu S., Cheng W., Zheng J., Luo J.H. Fluorescence resonance energy transfer analysis of subunit assembly of the ASIC channel. Biochem. Biophys. Res. Commun. 2007, 359(1):143-150.
11. Guarnieri M., Kim K.H., Bang G., Li J., Zhou Y., Tang X., Wands J., Tong S. Point mutations upstream of hepatitis B virus core gene affect DNA replication at the step of core protein expression. J. Virol. 2006, 80(2):587-595.
12. Harris R.S., Bishop K.N., Sheehy A.M., Craig H.M., Petersen-Mahrt S.K., Watt I.N., Neuberger M.S., Malim M.H. DNA deamination mediates innate immunity to retroviral infection. Cell 2003, 113(6):803-809.
13. Hu J.L., Cui J., Deng X.Y., Zhang W.L., Li Q.L., Guo J.J., Zeng A.Z., Huang A.L. A new strategy for constructing in vitro replication-competent 1.3 copies of hepatitis B virus genome. J. Virol. Methods 2009, 161(1):63-69.
14. Jarmuz A., Chester A., Bayliss J., Gisbourne J., Dunham I., Scott J., Navaratnam N. An anthropoid-specific locus of orphan C to U RNA-editing enzymes on chromosome 22. Genomics 2002, 79(3):285-296.
15. Kao J.H., Chen D.S. Global control of hepatitis B virus infection. Lancet Infect. Dis. 2002, 2(7):395-403.
16. Karpova T.S., Baumann C.T., He L., Wu X., Grammer A., Lipsky P., Hager G.L., McNally J.G. Fluorescence resonance energy transfer from cyan to yellow fluorescent protein detected by acceptor photobleaching using confocal microscopy and a single laser. J. Microsc. 2003, 209(Pt 1):56-70.
17. Liao W., Ou J.H. Phosphorylation and nuclear localization of the hepatitis B virus core protein: significance of serine in the three repeated SPRRR motifs. J. Virol. 1995, 69(2):1025-1029.
18. Mangeat B., Turelli P., Caron G., Friedli M., Perrin L., Trono D. Broad antiretroviral defence by human APOBEC3G through lethal editing of nascent reverse transcripts. Nature 2003, 424(6944):99-103.
19. Nakajima H., Cocquerel L., Kiyokawa N., Fujimoto J., Levy S. Kinetics of HCV envelope proteins' interaction with CD81 large extracellular loop. Biochem. Biophys. Res. Commun. 2005, 328(4):1091-1100.
20. Nassal M. The arginine-rich domain of the hepatitis B virus core protein is required for pregenome encapsidation and productive viral positive-strand DNA synthesis but not for virus assembly. J. Virol. 1992, 66(7):4107-4116.
21. Nguyen D.H., Gummuluru S., Hu J. Deamination-independent inhibition of hepatitis B virus reverse transcription by APOBEC3G. J. Virol. 2007, 81(9):4465-4472.
22. Nguyen D.H., Hu J. Reverse transcriptase- and RNA packaging signal-dependent incorporation of APOBEC3G into hepatitis B virus nucleocapsids. J. Virol. 2008, 82(14):6852-6861.
23. Ning B., Shih C. Nucleolar localization of human hepatitis B virus capsid protein. J. Virol. 2004, 78(24):13653-13668.
24. Schlicht H.J., Bartenschlager R., Schaller H. The duck hepatitis B virus core protein contains a highly phosphorylated C terminus that is essential for replication but not for RNA packaging. J. Virol. 1989, 63(7):2995-3000.
25. Sells M.A., Chen M.L., Acs G. Production of hepatitis B virus particles in Hep G2 cells transfected with cloned hepatitis B virus DNA. Proc. Natl. Acad. Sci. U.S.A. 1987, 84(4):1005-1009.
26. Sureau C., Romet-Lemonne J.L., Mullins J.I., Essex M. Production of hepatitis B virus by a differentiated human hepatoma cell line after transfection with cloned circular HBV DNA. Cell 1986, 47(1):37-47.
27. Soros V.B., Yonemoto W., Greene W.C. Newly synthesized APOBEC3G is incorporated into HIV virions, inhibited by HIV RNA, and subsequently activated by RNase H. PLoS Pathog. 2007, 3(2):e15.
28. Takanishi C.L., Bykova E.A., Cheng W., Zheng J. GFP-based FRET analysis in live cells. Brain. Res. 2006, 1091(1):132-139.
29. Turelli P., Mangeat B., Jost S., Vianin S., Trono D. Inhibition of hepatitis B virus replication by APOBEC3G. Science 2004, 303(5665):1829.
30. Wang S.M., Wang C.T. APOBEC3G cytidine deaminase association with coronavirus nucleocapsid protein. Virology 2009, 388(1):112-120.
31. Wang T., Tian C., Zhang W., Sarkis P.T., Yu X.F. Interaction with 7SL RNA but not with HIV-1 genomic RNA or P bodies is required for APOBEC3F virion packaging. J. Mol. Biol. 2008, 375(4):1098-1112.
32. Wang T., Zhang W., Tian C., Liu B., Yu Y., Ding L., Spearman P., Yu X.F. Distinct viral determinants for the packaging of human cytidine deaminases APOBEC3G and APOBEC3C. Virology 2008, 377(1):71-79.
33. Wedekind J.E., Dance G.S., Sowden M.P., Smith H.C. Messenger RNA editing in mammals: new members of the APOBEC family seeking roles in the family business. Trends Genet. 2003, 19(4):207-216.
34. Wichroski M.J., Robb G.B., Rana T.M. Human retroviral host restriction factors APOBEC3G and APOBEC3F localize to mRNA processing bodies. PLoS Pathog. 2006, 2(5):e41.
35. Zhang L., Li X., Ma J., Yu L., Jiang J., Cen S. The incorporation of APOBEC3 proteins into murine leukemia viruses. Virology 2008, 378(1):69-78.